Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (631)
|
Core Tip (726)
|
Full Article (HTML) (2400)
|
Figures (1-1) (459)
|
Full Article (PDF)-1204K (191)
|
Full Article with Cover (PDF)-11949K (223)
|
Full Article (XML)-236K (119)
|
Audio-1342K (9)
|
Peer-Review Report-230K (127)
|
Answering Reviewers-97K (114)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (7383)
|
Similar Articles (77)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (671)
|
Core Tip (721)
|
Full Article (HTML) (1753)
|
Tables (1-1) (553)
|
Full Article (PDF)-358K (158)
|
Full Article with Cover (PDF)-11106K (195)
|
Full Article (XML)-54K (107)
|
Audio-1072K (10)
|
Peer-Review Report-236K (100)
|
Answering Reviewers-62K (94)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6077)
|
Similar Articles (21)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (759)
|
Core Tip (616)
|
Full Article (HTML) (6809)
|
Figures (1-2) (499)
|
Tables (1-5) (499)
|
Full Article (PDF)-1655K (269)
|
Full Article with Cover (PDF)-12399K (222)
|
Full Article (XML)-226K (128)
|
Audio-1259K (9)
|
Peer-Review Report-216K (110)
|
Answering Reviewers-145K (105)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (16)
|
Total Visits (11361)
|
Similar Articles (64)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (745)
|
Core Tip (664)
|
Full Article (HTML) (3708)
|
Figures (1-1) (493)
|
Full Article (PDF)-601K (271)
|
Full Article with Cover (PDF)-11346K (161)
|
Full Article (XML)-89K (118)
|
Audio-384K (5)
|
Peer-Review Report-180K (99)
|
Answering Reviewers-74K (113)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (17)
|
Total Visits (7884)
|
Similar Articles (338)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (718)
|
Core Tip (633)
|
Article Highlights (650)
|
Full Article (HTML) (2460)
|
Figures (1-4) (439)
|
Tables (1-3) (437)
|
Full Article (PDF)-1672K (165)
|
Full Article with Cover (PDF)-12418K (161)
|
Full Article (XML)-173K (103)
|
Audio-467K (7)
|
Peer-Review Report-182K (91)
|
Answering Reviewers-71K (129)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8094)
|
Similar Articles (2046)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (684)
|
Core Tip (693)
|
Article Highlights (798)
|
Full Article (HTML) (2152)
|
Figures (1-3) (521)
|
Tables (1-2) (478)
|
Full Article (PDF)-1874K (180)
|
Full Article with Cover (PDF)-12619K (194)
|
Full Article (XML)-114K (127)
|
Audio-386K (17)
|
Peer-Review Report-233K (116)
|
Answering Reviewers-161K (114)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (9339)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (600)
|
Core Tip (570)
|
Article Highlights (648)
|
Full Article (HTML) (1535)
|
Figures (1-4) (424)
|
Full Article (PDF)-5746K (156)
|
Full Article with Cover (PDF)-16492K (144)
|
Full Article (XML)-96K (111)
|
Audio-3997K (8)
|
Peer-Review Report-192K (97)
|
Answering Reviewers-146K (109)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6474)
|
Similar Articles (43)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (677)
|
Core Tip (651)
|
Article Highlights (687)
|
Full Article (HTML) (2715)
|
Figures (1-4) (425)
|
Tables (1-5) (452)
|
Full Article (PDF)-6006K (197)
|
Full Article with Cover (PDF)-16750K (176)
|
Full Article (XML)-200K (108)
|
Audio-376K (6)
|
Peer-Review Report-182K (117)
|
Answering Reviewers-60K (116)
|
Supplementary Material-355K (112)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (10146)
|
Similar Articles (1896)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (609)
|
Core Tip (673)
|
Article Highlights (657)
|
Full Article (HTML) (1879)
|
Figures (1-4) (445)
|
Tables (1-4) (441)
|
Full Article (PDF)-5941K (159)
|
Full Article with Cover (PDF)-16687K (156)
|
Full Article (XML)-115K (112)
|
Audio-187K (10)
|
Peer-Review Report-215K (105)
|
Answering Reviewers-37K (123)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8038)
|
Similar Articles (2529)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (647)
|
Core Tip (644)
|
Full Article (HTML) (1622)
|
Figures (1-1) (510)
|
Full Article (PDF)-5068K (181)
|
Full Article with Cover (PDF)-15813K (151)
|
Full Article (XML)-63K (101)
|
Audio-811K (4)
|
Peer-Review Report-266K (118)
|
Answering Reviewers-225K (117)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6745)
|
Similar Articles (4350)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (647)
|
Core Tip (687)
|
Full Article (HTML) (1620)
|
Full Article (PDF)-325K (132)
|
Full Article with Cover (PDF)-11079K (150)
|
Full Article (XML)-24K (111)
|
Audio-243K (4)
|
Peer-Review Report-215K (87)
|
Answering Reviewers-19K (92)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4907)
|
Similar Articles (398)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open